CPT℠ management has launched a comprehensive approach to assess our readiness across all critical departmental functions, during the evolving situation surrounding COVID-19 and Executive Order 107 and 108 effective Saturday (3/21/20) in New Jersey. CPT℠ remains committed to ensuring our clients get the personalized service which is our hallmark, combined with the ethical generation of data essential to your business. The well-being of our staff, subject population, clients and suppliers is our primary concern.

To achieve this, we are:

  • Activating our business continuity planning to assess readiness throughout each laboratory
  • Continuing compliance with CDC, WHO, and governmental authority recommendations
  • Remote access capabilities for employees, clients, auditors and monitors
  • Scenario planning for a reduced number of human resources
  • Daily review and implementation of best practices

Current Impact on Operations
We are not experiencing any delays in initiation of testing in our analytical chemistry, microbiology, and in-vitro laboratories and CPT℠ has no plans to temporarily discontinue those operations at this time. We are providing critical services and consultation to our clients in the pharmaceutical, therapeutic, medical device and personal care industries. We are monitoring and adapting as quickly as possible to the rapidly changing situation. Should our situation change, we will be notifying you of further developments.

However, based upon our compliance with Executive Order 107 and 108 here in NJ, we are discontinuing the initiation of new photobiology and clinical trials at this time. The well-being of our staff and subject population is our primary concern. We had previously instituted measures consistent with the CDC, WHO and local government and health recommendations and now we must increase our protection of staff and our subject population. Our clinical management team will be assessing the status of ongoing studies, and you will be contacted to ensure that your photobiology or clinical trial is closed out to the best of our ability and provided the opportunity to restart where needed. Studies in our queue will be postponed and you will be contacted with future dates once we have clarity on when we can reopen. Please be patient while we go through this process.

Should you have any questions, please contact your CPT℠ Account Manager or Client Services If you are not signed up for eCPT℠ client access system, please contact Client Services.

Thank you for your continued support. Through all of this, we are re-emphasizing what is most important – our team members, our communities and you.

Thank you,
CPT℠ Labs Management